Article
Evaluating SARS-CoV-2 antibody resilience via prediction and design of escape viral variants.
Cell systems - 16 Sept 2026
Huot Marian, Rosenbaum Pierre, Planchais Cyril, Mouquet Hugo, Monasson Rémi, Cocco Simona
Abstract excerpt
The evolutionary trajectory of SARS-CoV-2 is shaped by competing pressures for angiotensin-converting enzyme 2 (ACE2) binding, viability, and escape from neutralizing antibodies targeting its receptor-binding domain (RBD). Here, we present EscapeMap, a modular framework that enables the prediction and design of variants escaping antibodies. EscapeMap integrates deep mutational scanning data for ACE2 and 31...
Read the complete abstract on PubMedTopics
- SARS-CoV-2
- Humans
- Antibodies, Neutralizing
- Angiotensin-Converting Enzyme 2
- Mutation
- Antibodies, Viral
